Replies to post #1850 on Revance Therapeutics Inc (RVNC)

[jmkobers]

<<in a non-hedging situation would only do so if he had access to potentially worse news than further inspection delays. The likely culprit would be some significant flaw in the data submitted to the FDA.>>

Thanks for discussing, as I think abut it more, the above seems pretty unlikely. Unless, that is, the purchaser is a buffoon whose lifelong dream is to do hard time, not make money.

Regards, Joe